These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10958946)

  • 1. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: relationship with cancer-related genes and fragile sites.
    López de Mesa R; Sierrasesúmaga L; Calasanz MJ; López de Cerain AL; Patiño-García A
    Cancer Genet Cytogenet; 2000 Aug; 121(1):78-85. PubMed ID: 10958946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer].
    López de Mesa R; Sierrasesúmaga L; Calasanz MJ; López de Cerain A; Patiño A
    Rev Med Univ Navarra; 2000; 44(1):15-24. PubMed ID: 11002895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients.
    López de Mesa R; López de Ceráin Salsamendi A; Ariznabarreta LS; Calasanz Abínzano MJ; Patiño-García A
    Mutagenesis; 2002 Mar; 17(2):171-5. PubMed ID: 11880547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of MspI-induced breaks in human lymphocyte chromosomes and its relationship to common fragile sites.
    Porfirio B; Tedeschi B; Vernole P; Caporossi D; Nicoletti B
    Mutat Res; 1989 Aug; 213(2):117-24. PubMed ID: 2474762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chromosomal restructurings and the distribution of chromosome fragile sites in the peripheral blood lymphocytes in a breast cancer patient after cytostatic therapy].
    Iakovleva TK; Monakhov AS; Moiseenko VM
    Tsitologiia; 1992; 34(2):77-83. PubMed ID: 1322577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further localization of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23).
    Simmers RN; Sutherland GR
    Hum Genet; 1988 Feb; 78(2):144-7. PubMed ID: 3422214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome abnormalities and fragile sites in human melanoma.
    Sozzi G; Miozzo M; Calderone C; Fossati G; Pierotti MA; Cascinelli N; Della Porta G
    Cancer Genet Cytogenet; 1990 Jan; 44(1):61-7. PubMed ID: 2293881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints.
    Fundia A; Gorla N; Larripa I
    Hereditas; 1994; 120(1):47-50. PubMed ID: 8206783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome fragility and predisposition to childhood malignancies.
    Kolialexi A; Mavrou A; Tsenghi C; Tsangaris GT; Dafermou E; Tzortzatou F; Polychronopoulou S; Haidas S; Metaxotou C
    Anticancer Res; 1998; 18(4A):2359-64. PubMed ID: 9703879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of fragile sites induced by pyrimethamine.
    Egeli U; Tunca B
    Teratog Carcinog Mutagen; 1997; 17(2):59-69. PubMed ID: 9261920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between chemical-induced fragile sites and chromosomal breakpoints in malignant cells in children.
    Ribeiro RC; Douglass EC; Williams DL; Raimondi SC; Valentine M; Lewis S; Crist WM
    Leuk Lymphoma; 1992 Aug; 7(5-6):401-7. PubMed ID: 1493441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of X-ray-induced chromosome breakpoints in Down syndrome lymphocytes.
    Shafik HM; Au WW; Whorton EB; Legator MS
    Am J Med Genet Suppl; 1990; 7():195-200. PubMed ID: 2149946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites.
    Barbi G; Steinbach P; Vogel W
    Hum Genet; 1984; 68(4):290-4. PubMed ID: 6239815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
    Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
    Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency.
    Chary-Reddy S; Prasad VS; Ahuja YR
    Cancer Lett; 1994 Oct; 86(1):111-7. PubMed ID: 7954347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Karyotypic anomalies and chromosomal sites of increased fragility in colorectal cancer].
    Sokova OI; Kirichenko OP; Kulagina OE; Konstantinova LN; Chebotarev AN; Fleĭshman EV
    Genetika; 1997 Sep; 33(9):1297-302. PubMed ID: 9445823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile sites and breakpoints in constitutional rearrangements and in human sperm chromosomes.
    Fuster C; Miró R; Templado C; Barrios L; Moreno V; Egozcue J
    Hum Genet; 1989 Jul; 82(4):330-4. PubMed ID: 2737665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile sites and structural rearrangements in cancer.
    De Braekeleer M; Smith B; Lin CC
    Hum Genet; 1985; 69(2):112-6. PubMed ID: 3972412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
    Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
    Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.